Effect of Delay in Initiation of Adjuvant Trastuzumab and Dose Interruptions on Overall Treatment Outcome in Breast Cancer Patients, a Retrospective Study
ConclusionWe concluded that delays in the initiation of adjuvant treatment may be particularly harmful in patients with more aggressive tumor types.
Source: QJM - Category: Internal Medicine Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Herceptin | Internal Medicine | Nuclear Medicine | Statistics | Study